Boehringer Ingelheim
Boehringer Ingelheim is a Public Limited Company registered in United States, and its current status with Connecticut Secretary of the State — business.ct.gov is active. Its registered address on file is ridgefield, United States. No shareholders are recorded for Boehringer Ingelheim; ownership in this jurisdiction is held as the stock ledger under state corporate law (e.g. §219 of the Delaware General Corporation Law), a record kept privately rather than filed publicly. No beneficial owner (UBO) data is recorded for Boehringer Ingelheim; access to beneficial-ownership data in this jurisdiction is governed by its own register rules. This profile is sourced directly from Connecticut Secretary of the State — business.ct.gov and was last updated on 29 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
3
Three officers are currently on record for Boehringer Ingelheim, filed with Connecticut Secretary of the State — business.ct.gov. Edward Gonzalez serves as Director, Clinical Study Management & Conduct – Oncology; Patrick Murphy and Kim Griffin both serve as Marketing.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who is Boehringer Ingelheim's UBO (Ultimate Beneficial Owner)?
No Ultimate Beneficial Owner (UBO) data is recorded for Boehringer Ingelheim; access to beneficial-ownership data in this jurisdiction is governed by its own register rules.
Is Boehringer Ingelheim still an active company?
Boehringer Ingelheim's status on Connecticut Secretary of the State — business.ct.gov is listed as active.
What is Boehringer Ingelheim's registered address?
The registered address on file for Boehringer Ingelheim is ridgefield, United States.
What legal structure is Boehringer Ingelheim registered as?
Boehringer Ingelheim is registered as a Public Limited Company in United States.
Who are the officers/directors of Boehringer Ingelheim?
Three officers are currently on record for Boehringer Ingelheim, filed with Connecticut Secretary of the State — business.ct.gov. Edward Gonzalez serves as Director, Clinical Study Management & Conduct – Oncology; Patrick Murphy and Kim Griffin both serve as Marketing.
Can Zavia monitor changes to Boehringer Ingelheim's ownership over time?
This profile reflects a point-in-time snapshot from Connecticut Secretary of the State — business.ct.gov. Zavia's monitoring API can track changes to Boehringer Ingelheim's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Boehringer Ingelheim's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Boehringer Ingelheim's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Connecticut Secretary of the State — business.ct.gov and was last synced on 29 September 2026.